EUR 0.08
(-1.89%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -6.51 Million EUR | -107.52% |
2022 | -3.13 Million EUR | -98.17% |
2021 | -1.58 Million EUR | 88.73% |
2020 | -14.04 Million EUR | -388.49% |
2019 | -2.87 Million EUR | 30.26% |
2018 | -4.12 Million EUR | -327.36% |
2017 | -965 Thousand EUR | 64.13% |
2016 | -2.69 Million EUR | -59.59% |
2015 | -1.68 Million EUR | -1.13% |
2014 | -1.66 Million EUR | -3141.89% |
2013 | -51.41 Thousand EUR | -112.54% |
2012 | 409.88 Thousand EUR | 71.78% |
2011 | 238.61 Thousand EUR | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | -3.38 Million EUR | 0.0% |
2023 Q4 | -4.61 Million EUR | 0.0% |
2023 Q2 | -1.89 Million EUR | 0.0% |
2023 FY | -6.51 Million EUR | -107.52% |
2022 Q2 | -803 Thousand EUR | 0.0% |
2022 FY | -3.13 Million EUR | -98.17% |
2022 Q4 | -2.33 Million EUR | 0.0% |
2021 FY | -1.58 Million EUR | 88.73% |
2021 Q2 | -617 Thousand EUR | 0.0% |
2021 Q4 | -966 Thousand EUR | 0.0% |
2020 Q4 | -2.09 Million EUR | 0.0% |
2020 FY | -14.04 Million EUR | -388.49% |
2020 Q2 | -12.01 Million EUR | 0.0% |
2019 Q2 | -1.61 Million EUR | 0.0% |
2019 Q4 | -1.26 Million EUR | 0.0% |
2019 FY | -2.87 Million EUR | 30.26% |
2018 Q2 | -1.92 Million EUR | 0.0% |
2018 FY | -4.12 Million EUR | -327.36% |
2018 Q4 | -2.19 Million EUR | 0.0% |
2017 Q2 | 650 Thousand EUR | 0.0% |
2017 FY | -965 Thousand EUR | 64.13% |
2017 Q4 | -1.61 Million EUR | 0.0% |
2016 Q2 | -940 Thousand EUR | 0.0% |
2016 FY | -2.69 Million EUR | -59.59% |
2016 Q4 | -1.75 Million EUR | 0.0% |
2015 FY | -1.68 Million EUR | -1.13% |
2015 Q4 | -795.91 Thousand EUR | 0.0% |
2015 Q2 | -889.61 Thousand EUR | 0.0% |
2014 Q4 | -1.12 Million EUR | 0.0% |
2014 Q2 | -541.95 Thousand EUR | 0.0% |
2014 FY | -1.66 Million EUR | -3141.89% |
2013 FY | -51.41 Thousand EUR | -112.54% |
2013 Q4 | 208.38 Thousand EUR | 0.0% |
2013 Q2 | -259.79 Thousand EUR | 0.0% |
2012 Q1 | 102.47 Thousand EUR | 0.0% |
2012 Q2 | 102.47 Thousand EUR | 0.0% |
2012 Q3 | 102.47 Thousand EUR | 0.0% |
2012 Q4 | -12.85 Thousand EUR | -112.54% |
2012 FY | 409.88 Thousand EUR | 71.78% |
2011 Q3 | 59.65 Thousand EUR | 0.0% |
2011 Q4 | 102.47 Thousand EUR | 71.78% |
2011 FY | 238.61 Thousand EUR | 0.0% |
2011 Q1 | 59.65 Thousand EUR | 0.0% |
2011 Q2 | 59.65 Thousand EUR | 0.0% |
2010 Q4 | 59.65 Thousand EUR | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Crossject Société Anonyme | -8.63 Million EUR | 24.635% |
Safe Orthopaedics SA | -6.96 Million EUR | 6.533% |
Amplitude Surgical SA | 1.5 Million EUR | 534.0% |
Sartorius Stedim Biotech S.A. | 309.7 Million EUR | 102.102% |
EssilorLuxottica Société anonyme | 2.28 Billion EUR | 100.284% |
bonyf N.V. | -1.04 Million EUR | -523.142% |